Concepedia

R Cacabelos

RC

Statistics

Publications

5

Citations

311

H-Index

5

Active since

1994

Affiliations

EuroEspes Biomedical Research Center(Current)

EVER Neuro Pharma (Austria)

R Cacabelos is an author at EuroEspes Biomedical Research Center specializing in neuroprotection, neuropharmacology, and neuroscience.

Publications per year

1994–2006

5

Publications

5

A 24‐week, double‐blind, placebo‐controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease

X.A. Alvarez, R Cacabelos, M. Laredo et al. · European Journal of Neurology · 2006 · 98 citations

, , +15

Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics.

R Cacabelos, Valter Lombardi, L. Fernández‐Novoa et al. · PubMed · 2000 · 70 citations

, , +17

Cerebrolysin® reduces microglial activation in vivo and in vitro: a potential mechanism of neuroprotection

X. Anton Álvarez, Valter Lombardi, L. Fernández‐Novoa et al. · 2000 · 59 citations

, , +17

Positive effects of Cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study

X. Ant n lvarez, Carolina Sampedro, Paula P rez et al. · International Clinical Psychopharmacology · 2003 · 47 citations

, , +15

Effects of CDP-choline on cognition and cerebral hemodynamics in patients with Alzheimer's disease.

José Carlos Caamaño, Annalisa Franco, R Cacabelos · PubMed · 1994 · 37 citations

, , +17

1–5 of 5